MannKind Corporation
US ˙ NasdaqGM ˙ US56400P7069

Introduction

This page provides a comprehensive analysis of the known insider trading history of Matthew J Pfeffer. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Matthew J Pfeffer has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EYES / Vivani Medical Inc Director 56,685
US:MNKD / MannKind Corporation Director 81,961
US:DSKX / DS Healthcare Group, Inc. Director 10,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Matthew J Pfeffer. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MNKD / MannKind Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MNKD / MannKind Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-06-30 MNKD PFEFFER MATTHEW J 2,000 1.2300 2,000 1.2300 2,460 102 6.7100 10,960 445.53
2017-01-03 MNKD PFEFFER MATTHEW J 4,540 0.5400 908 2.7000 2,452
2016-08-15 MNKD PFEFFER MATTHEW J 25,000 0.9860 5,000 4.9300 24,650
2014-06-30 MNKD PFEFFER MATTHEW J 527 4.4200 105 22.1000 2,329
2013-12-31 MNKD PFEFFER MATTHEW J 487 4.5300 97 22.6500 2,206
2013-06-30 MNKD PFEFFER MATTHEW J 7,448 1.9600 1,490 9.8000 14,598
2012-12-31 MNKD PFEFFER MATTHEW J 1,056 1.9500 211 9.7500 2,059
2012-06-30 MNKD PFEFFER MATTHEW J 1,054 1.9500 211 9.7500 2,055

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MNKD / MannKind Corporation Insider Trades
Insider Sales MNKD / MannKind Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MNKD / MannKind Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2013-08-01 MNKD PFEFFER MATTHEW J 10,000 8.0000 2,000 40.0000 80,000 243 4.2000 -71,600 -89.50

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MNKD / MannKind Corporation Insider Trades
Insider Purchases VANI / Vivani Medical, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MNKD / MannKind Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VANI / Vivani Medical, Inc. Insider Trades
Insider Sales VANI / Vivani Medical, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MNKD / MannKind Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VANI / Vivani Medical, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Matthew J Pfeffer as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2019-06-05 2019-06-04 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Non-Qualified Stock Option(right to buy)
A - Award 56,685 56,685
2018-06-05 2018-06-02 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Non Qualified Stock Option (right to buy)
A - Award 25,970 25,970
2018-06-05 2018-06-01 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
A - Award 35,533 118,301 42.93
2017-08-29 2017-08-28 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -303 81,961 -0.37 1.55 -470 127,040
2017-08-23 2017-08-22 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -170 82,264 -0.21 1.41 -240 115,992
2017-08-23 2017-08-21 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -183 82,434 -0.22 1.46 -267 120,354
2017-08-23 2017-06-30 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 2,000 82,617 2.48 1.23 2,460 101,619
2017-06-05 2017-06-01 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
A - Award 59,725 82,768 259.19 1.17 69,998 97,004
2017-03-16 2017-03-14 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Warrant to Purchase Common Stock
A - Award 5,582 5,582
2017-03-16 2017-03-14 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
COMMON STOCK
A - Award 5,582 23,043 31.97 1.47 8,206 33,873
2017-01-04 2017-01-03 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 4,540 403,085 1.14 0.54 2,452 217,666
2016-08-16 2016-08-15 4 MNKD MANNKIND CORP
Common Stock,$.01 par value
P - Purchase 25,000 397,996 6.70 0.99 24,650 392,424
2016-06-03 2016-06-01 4 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
A - Award 17,461 17,461 3.95 68,997 68,997
2016-02-29 2016-02-18 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 1,345,300 1,345,300 0.92 1,237,676 1,237,676
2016-02-29 2016-02-18 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 604,267 604,267 0.92 555,926 555,926
2015-09-03 2015-08-27 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 72,300 72,300 3.91 282,693 282,693
2015-09-03 2015-08-27 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
A - Award 16,100 372,996 4.51
2015-09-03 2015-08-22 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -846 356,896 -0.24 3.79 -3,206 1,352,636
2015-09-03 2015-08-21 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -912 357,742 -0.25 3.79 -3,456 1,355,842
2015-09-03 2015-08-18 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,598 358,654 -0.44 4.15 -6,632 1,488,414
2015-09-03 2015-08-16 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,598 360,252 -0.44 4.09 -6,536 1,473,431
2015-02-25 2015-02-23 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
F - Taxes -5,975 361,850 -1.62 6.43 -38,419 2,326,696
2015-02-25 2015-02-23 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
A - Award 15,000 367,825 4.25
2015-02-25 2015-02-03 4 MNKD MANNKIND CORP
Employee Stock Option
M - Exercise 60,000 60,000
2015-02-13 2014-10-31 5 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
G - Gift -1,000 352,825 -0.28
2015-02-13 2014-04-22 5 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
G - Gift -100 353,825 -0.03
2014-08-26 2014-08-22 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
F - Taxes -1,175 373,925 -0.31 7.09 -8,331 2,651,128
2014-08-26 2014-08-21 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 43,400 43,400
2014-08-26 2014-08-21 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
A - Award 9,700 375,100 2.65
2014-08-26 2014-08-11 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 180,000 450,000 66.67
2014-08-26 2014-08-11 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 60,000 140,000 75.00
2014-08-26 2014-08-11 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
F - Taxes -114,796 365,400 -23.91 8.53 -979,210 3,116,862
2014-08-26 2014-08-11 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
A - Award 220,000 480,196 84.55
2014-08-19 2014-08-19 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,696 240,196 -0.70 7.23 -12,262 1,736,617
2014-08-19 2014-08-18 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -2,218 241,892 -0.91 6.86 -15,215 1,659,379
2014-08-19 2014-08-16 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -2,218 244,110 -0.90 6.86 -15,215 1,674,595
2014-07-17 2014-06-27 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 180,000 270,000 200.00
2014-07-17 2014-06-27 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 80,000 140,000 133.33
2014-07-17 2014-06-27 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 36,000 37,400 2,571.43
2014-07-17 2014-06-27 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
F - Taxes -109,456 246,328 -30.76 10.00 -1,094,560 2,463,280
2014-07-17 2014-06-27 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
A - Award 229,000 465,240 96.94
2014-07-17 2013-11-21 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 90,000 90,000
2014-07-17 2013-10-14 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 60,000 60,000
2014-07-03 2014-07-01 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
S - Sale X -20,000 126,784 -13.63 10.44 -208,768 1,323,422
2014-06-30 2014-06-30 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 527 146,784 0.36 4.42 2,329 648,785
2014-06-06 2014-06-05 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
M - Exercise -10,000 10,300 -49.26
2014-06-06 2014-06-05 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
D - Sale to Issuer X -10,000 146,257 -6.40 11.00 -110,000 1,608,827
2014-06-06 2014-06-05 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
A - Award 10,000 156,257 6.84 2.23 22,300 348,453
2014-06-06 2014-06-04 4 MNKD MANNKIND CORP
Common Stock, $0.01 Par Value
S - Sale X -10,000 146,257 -6.40 10.00 -100,000 1,462,570
2014-04-03 2014-02-05 4 DSKX DS HEALTHCARE GROUP, INC.
Common Stock
A - Award 5,000 10,000 100.00
2014-02-18 2012-11-27 4/A DSKX DS HEALTHCARE GROUP, INC.
Common Stock
A - Award 5,000 5,000
2014-01-03 2013-12-31 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 487 156,257 0.31 4.53 2,206 707,844
2013-11-27 2013-11-21 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -41,338 155,770 -20.97 4.88 -201,729 760,158
2013-11-27 2013-11-21 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
A - Award 110,000 197,108 126.28
2013-08-29 2013-08-22 4 MNKD MANNKIND CORP
Employee Stock Option (right to buy)
A - Award 50,000 50,000 5.89 294,500 294,500
2013-08-29 2013-08-22 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
A - Award 9,000 87,108 11.52
2013-08-20 2013-08-19 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,222 78,108 -1.54 5.77 -7,051 450,683
2013-08-20 2013-08-19 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,128 79,330 -1.40 5.77 -6,509 457,734
2013-08-20 2013-08-18 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,598 80,458 -1.95 5.77 -9,220 464,243
2013-08-20 2013-08-16 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
F - Taxes -1,598 82,056 -1.91 6.64 -10,611 544,852
2013-08-02 2013-08-01 4 MNKD MANNKIND CORP
Employee Stock Option
M - Exercise -10,000 1,400 -87.72
2013-08-02 2013-08-01 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
S - Sale -10,000 83,654 -10.68 8.00 -80,000 669,232
2013-08-02 2013-08-01 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
M - Exercise X 10,000 93,654 11.95 2.86 28,600 267,850
2013-07-03 2013-07-02 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
S - Sale X -10,000 83,654 -10.68 7.00 -70,000 585,578
2013-07-02 2013-06-30 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 7,448 93,654 8.64 1.96 14,598 183,562
2013-05-17 2013-05-15 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
S - Sale X -10,000 86,206 -10.39 5.00 -50,000 431,030
2013-01-03 2012-12-31 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 1,056 96,206 1.11 1.95 2,059 187,602
2012-11-28 2012-11-27 4 DSKX Divine Skin Inc.
Restricted Stock Grant
A - Award 12,500 12,500
2012-11-28 2012-11-27 4 DSKX Divine Skin Inc.
Restricted Stock Grant
A - Award 12,500 12,500
2012-11-28 2012-11-27 4 DSKX Divine Skin Inc.
Restricted Stock Grant
A - Award 12,500 12,500
2012-11-28 2012-11-27 4 DSKX Divine Skin Inc.
Restricted Stock Grant
A - Award 12,500 12,500
2012-11-28 3 DSKX Divine Skin Inc.
Common Stock
0
2012-08-21 2012-08-16 4 MNKD MANNKIND CORP
Employee Stock Options (right to buy)
A - Award 72,000 72,000 2.32 167,040 167,040
2012-08-21 2012-08-16 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
A - Award 17,000 95,150 21.75
2012-07-03 2012-06-30 4 MNKD MANNKIND CORP
Common Stock, $.01 Par Value
P - Purchase 1,054 78,150 1.37 1.95 2,055 152,392
2012-05-21 2012-05-17 4 MNKD MANNKIND CORP
Employee Stock Options (right to buy)
A - Award 200,000 200,000 1.69 338,000 338,000
2012-02-14 2011-12-31 5 MNKD MANNKIND CORP
Common Stock, $.01 par value
A - Award 931 77,096 1.22 2.13 1,983 164,214
2012-02-14 2011-06-30 5 MNKD MANNKIND CORP
Common Stock, $.01 par value
A - Award 592 77,096 0.77 3.28 1,942 252,875
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)